São Paulo - Delayed Quote • BRL
Brasil Pharma S.A. (BPHA3.SA)
At close: June 10 at 5:05 PM GMT-3
Loading Chart for BPHA3.SA
DELL
- Previous Close
0.6200 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.6200 - 0.6200 - 52 Week Range
0.6200 - 0.6200 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
70.11M - Beta (5Y Monthly) --
- PE Ratio (TTM)
0.06 - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
35.00
Related News
Performance Overview: BPHA3.SA
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
BPHA3.SA
0.00%
IBOVESPA
5.71%
1-Year Return
BPHA3.SA
0.00%
IBOVESPA
22.58%
3-Year Return
BPHA3.SA
0.00%
IBOVESPA
4.97%
5-Year Return
BPHA3.SA
56.03%
IBOVESPA
31.04%
Compare To: BPHA3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BPHA3.SA
Valuation Measures
As of 4/27/2024
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
17.08
Enterprise Value/EBITDA
0.12
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: BPHA3.SA
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker
Company Insights: BPHA3.SA
BPHA3.SA does not have Company Insights